Association of Serum Cystatin C With Cerebral Small Vessel Disease in Community-Based Population

  • Dongxiao Yao
  • , Shan Li
  • , Jing Jing
  • , Xueli Cai
  • , Aoming Jin
  • , Yingying Yang
  • , Suying Wang
  • , Xia Meng
  • , Jinxi Lin
  • , Lerong Mei
  • , Hao Li
  • , Tiemin Wei
  • , Yongjun Wang
  • , Yuesong Pan
  • , Yilong Wang

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

Background: The aim of this study was to investigate the relationship between serum cystatin C levels and the presence and severity of cerebral small vessel disease (CSVD). Methods: Community-dwelling residents in the Lishui city in China from the cross-sectional survey of the PRECISE (Poly-Vascular Evaluation for Cognitive Impairment and Vascular Events) cohort study were included in present study from 2017 to 2019. Total CSVD burden and modified total CSVD burden score, as well as the markers of CSVD on magnetic resonance imaging, including white matter hyperintensity, lacunes, cerebral microbleeds, and perivascular spaces, were assessed at baseline survey. Participants were divided into 4 groups according to the quartiles of cystatin C. The association of serum cystatin C with total CSVD burden and imaging markers was analyzed using ordinal or binary logistic regression models. Furthermore, 2-sample Mendelian randomization analysis was performed to investigate the genetically predicted effect of cystatin C on CSVD. Results: A total of 3061 participants were included in this study. The mean age of the participants was 61.2±6.7 years, and 1637 (53.5%) were women. Higher level of cystatin C was associated with an increased total CSVD burden and modified total CSVD burden (Q4 versus Q1: common odds ratio [OR], 1.30 [95% CI, 1.03-1.64] and 1.32 [95% CI, 1.01-1.73]) after adjustment for covariates. Further, compared with the first quartile of cystatin C, subjects in the last quartile had higher risk of lacunes (OR, 1.99 [95% CI, 1.05-3.76]), modified white matter hyperintensity burden (common OR, 1.42 [95% CI, 1.07-1.90]), and moderate-to-severe perivascular spaces (OR, 2.15 [95% CI, 1.29-3.59]) but not cerebral microbleeds. The Mendelian randomization analysis showed that a genetically predicted higher cystatin C level was associated with increased risk of lacunar stroke (OR, 1.16 [95% CI, 1.06-1.27]). Conclusions: In this community-based study, we found a possible association between cystatin C and CSVD, especially for lacunes, that was independent of estimated glomerular filtration rate.

Original languageEnglish
Pages (from-to)3123-3132
Number of pages10
JournalStroke
Volume53
Issue number10
DOIs
StatePublished - 1 Oct 2022
Externally publishedYes

Keywords

  • cerebral small vessel diseases
  • cystatin C
  • humans
  • logistic models
  • white matter

Fingerprint

Dive into the research topics of 'Association of Serum Cystatin C With Cerebral Small Vessel Disease in Community-Based Population'. Together they form a unique fingerprint.

Cite this